Tyra Biosciences Inc (TYRA)
15.36
-0.51
(-3.21%)
USD |
NASDAQ |
Nov 21, 16:00
16.12
+0.76
(+4.95%)
After-Hours: 20:00
Tyra Biosciences Total Liabilities (Quarterly): 18.30M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.30M |
| June 30, 2024 | 16.42M |
| March 31, 2024 | 14.86M |
| December 31, 2023 | 21.60M |
| September 30, 2023 | 16.19M |
| June 30, 2023 | 11.44M |
| March 31, 2023 | 6.265M |
| December 31, 2022 | 8.352M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.229M |
| June 30, 2022 | 8.265M |
| March 31, 2022 | 7.787M |
| December 31, 2021 | 4.964M |
| September 30, 2021 | 6.239M |
| June 30, 2021 | 162.58M |
| December 31, 2020 | 29.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.964M
Minimum
Dec 2021
162.58M
Maximum
Jun 2021
22.74M
Average
11.44M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| Johnson & Johnson | 108.13B |
| PROCEPT BioRobotics Corp | 132.92M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 380.59M |
| Shareholders Equity (Quarterly) | 362.29M |